Skip to content
Search

Latest Stories

My way or high way: Locum pharmacists asked to accept lower rates or get shifts cancelled

Tesco, one of the leading pharmacy chains in the UK, has been allegedly accused of forcing some locum pharmacists to accept lower rates or it will cancel their booking. The issue has been brought to the notice of the Pharmacists' Defence Association (PDA) by some of its locum pharmacists members.

“Some locum pharmacists who had existing confirmed bookings at Tesco stores have reported to the PDA that the company has contacted them to say that if they do not agree to accept lower rates than have already agreed, the company will cancel their booking,” said PDA.


PDA Source: PDA

“The reported messages follow a communication from Tesco setting self-imposed so-called “wage rates” for locums. This is confusing as locums are self-employed and therefore should be able to negotiate rates with their clients just as any other independent supplier can do.  Using terminology such as “wage rates” is more indicative of an employer-employee relationship and could undermine the status of the locum market in community pharmacy. Employees are also entitled to various extra benefits and have greater employment rights.”

PDA shares examples of the messages received this week follow:

PDA 1

Concern raised over decision to keep the pharmacy close

The association also noticed that on various social media platforms it has been stated that the national shortage of pharmacists is causing the closure. PDA said, “Regulations state that a responsible pharmacist must be at the pharmacy for it to open and operate safely, and therefore, if the locum shift is cancelled, and no other pharmacist is engaged to cover the shift it must be closed, denying patients and communities the much-needed access to a pharmacy.  However, there appear to be no financial penalties for the business in closing, and they will still be able to receive payment from the NHS.”

“If a locum shift was agreed in advance but is cancelled by the employer, resulting in a closure, the PDA believe no reasonable person would describe that as there being a shortage of pharmacists.”

“In one part of the country, after the following screenshot relating to closures was shared multiple times on social media, it seems to have been deleted from a Facebook page called “Northallerton Community Champion”, said PDA.

“The page has thousands of followers and although it does not identify itself as being managed by Tesco, it seems to almost exclusively promote Tesco community involvement in that area and provides updates, talking in the first person when speaking about that Tesco store.”

PDA has urged, “If any locum did have a booking for Tuesday 19th, Saturday 23rd or Sunday 24th July at Tesco, North Allerton which was cancelled, they should contact the PDA with details.  The PDA also invite locums anywhere in the UK who experience similar treatment, to share evidence to support our campaign against these closures.”

“The epidemic of avoidable community pharmacy closures is truly shocking.  None of the Chief Pharmaceutical Officers, Health Ministers, Regulators or national NHS bodies should be unaware of this issue and the potential impact it has on patients and the public.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less